FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2151496 · Received July 6, 2011

Report

Report Number
2124215-2011-06754
Event Type
Injury
Date Received
July 6, 2011
Date of Event
April 1, 2011
Report Date
April 1, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE PORTION OF THE LEAD THAT WAS REMOVED FROM SERVICE WAS NOT RETURNED FOR TESTING. THEREFORE, BOSTON SCIENTIFIC CANNOT CONFIRM THE REPORTED CLINICAL OBSERVATIONS. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS ISSUE WILL BE RE-EVALUATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PACE/SENSE PORTION OF THIS LEAD WAS EXHIBITING IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS. ADDITIONALLY, THERE WERE SOME EVENTS RECORDED IN THE LOGBOOK WHICH THE DEVICE IDENTIFIED AS VENTRICULAR FIBRILLATION (VF) WHICH WAS NOISE AND NO THERAPY WAS DELIVERED. A REVISION PROCEDURE WAS PERFORMED AND THE PACE/SENSE PORTION OF THIS LEAD WAS REMOVED FROM SERVICE AND REPLACED WITHOUT FURTHER INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 56 YR E102| 0185| 4137| T175